Case Report
Accepted on 10 Jan 2025
Treatment of neuropathic pain with repeated low-dose methylenedioxymethamphetamine (MDMA): a case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1513022
- 450 views
Type at least 3 characters
538 articles
Articles
Review
Published on 10 Jan 2025
A systematic review and meta-analysis of the effects of combined aripiprazole on glycolipid metabolism in schizophrenia
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1496986
- 220 views
Perspective
Accepted on 07 Jan 2025
Bringing MDMA-Assisted Therapy for PTSD to Traditional Healthcare Systems: Tending to Set and Setting
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1433999
Original Research
Accepted on 27 Dec 2024
Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1506142
Correction
Published on 23 Dec 2024
Corrigendum: Physical disability and psychedelic therapies: an agenda for inclusive research and practice
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1523364
- 222 views
Original Research
Published on 20 Dec 2024
Clinical pharmacist recommendations in daily interdisciplinary ward rounds at a psychiatric hospital: a retrospective pre-post study on drug-related problems focused in somatic comorbidities
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1473832
- 327 views
Original Research
Published on 09 Dec 2024
Association between polypharmacy and the long-term prescription of hypnotics in Japan: a retrospective cross-sectional study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1471457
- 518 views
Systematic Review
Published on 09 Dec 2024
Phytochemicals in the treatment of patients with depression: a systemic review
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1509109
- 764 views
Case Report
Published on 04 Dec 2024
Pregabalin treatment in a 30-year-old patient with Bainbridge-Ropers syndrome: a case-report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1502773
- 945 views
Systematic Review
Published on 04 Dec 2024
Prevalence and solving strategies of drug-related problems in adult psychiatric inpatients - a systematic review
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1460098
- 455 views
Opinion
Published on 12 Nov 2024
Metformin in the management of antipsychotic-induced weight gain – why the ‘weight’?
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1491417
- 1,731 views
Editorial
Published on 12 Nov 2024
Editorial: Women in psychiatry 2023: psychopharmacology
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1488260
- 334 views
Case Report
Published on 07 Nov 2024
Vortioxetine as an alternative treatment for somatic symptom disorder: case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1496072
- 1,533 views
Opinion
Published on 06 Nov 2024
Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1485337
- 1,991 views
Original Research
Accepted on 01 Nov 2024
Exposure & response prevention versus risperidone for the treatment of tic disorders: a randomized controlled trial
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1360895
- 144 views
Original Research
Published on 01 Nov 2024
Country-specific psychopharmacological risk of reporting suicidality comparing 38 antidepressants and lithium from the FDA Adverse Event Reporting System, 2017–2023
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1442490
- 1,530 views